Seres Therapeutics (MCRB) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.5
-0.14
0.22
0.58

Details

Expected EPS
-0.077531
Actual EPS
0.58
Surprise EPS
0.66
Surprise Percent
+848.09%

Description

⁨Seres Therapeutics⁩ (⁦MCRB⁩) has reported earnings of ⁦0.58⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts